Neptune Wellness Solutions Inc. announced the appointment of David Mayers as Chief Operating Officer. Mr. Mayers brings to Neptune 30 years of senior level executive leadership experience and expertise in Corporate Strategy execution, M&A implementation, R&D, Quality, Supply Chain, Operations and Facility Expansion across several industries, including cannabis extraction, pharmaceuticals, healthcare, and health and wellness.
Mr. Mayers previously served as Chief Operating Officer of MediPharm Labs Inc., a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction where he was responsible for strategic direction and daily operation of the organization, including direct responsibility of Manufacturing, HR, R&D, IT, Security, Quality, Project Management, Procurement and Supply Chain. Prior to MediPharm, he served as Chief Executive Officer and Chief Operating Officer of Impopharma Inc., a specialty generic pharmaceutical company developing innovative nasal and pulmonary inhalation products for the U.S. market, where he was responsible for strategic direction and operation of the organization. Mr. Mayers previously served as President of WellSpring Pharma Services, a division of WellSpring Pharmaceuticals, as well as Vice President of Operations and Director of Quality Control at Purdue Pharma.
“David is a strategic, value-centered senior executive and a proven change agent who brings highly relevant industry experience to Neptune,” said Michael Cammarata, Chief Executive Officer of Neptune Wellness Solutions. “He is an accomplished hands-on leader and effective communicator well versed in developing highly collaborative teams, building culture, integrating people and processes, driving results and growth. As COO, he will play a critical role in implementing new systems and processes to drive Neptune’s operational excellence. I am very pleased to welcome David to the Neptune team and look forward to his contributions to our mission to redefine health and wellness, bring consumer packaged goods brands to market and deliver profitable growth.”
“I am excited to join Neptune as I believe the company has tremendous potential and is well positioned for growth,” said Mayers. “I look forward to leveraging my years of experience across key corporate functions in cannabis extraction, pharmaceuticals and healthcare to help Michael and the team execute the business strategy and drive growth across our B2B and B2C businesses.”
A trained chemist, Mr. Mayers graduated with honours from University of Guelph with a B.Sc. in Biological Sciences and earned his Masters in Business Administration from University of Toronto.